Oppenheimer Starts Insulet (PODD), Thoratec (THOR) at Outperform, DexCom (DXCM), HeartWare (HTWR) at Perform

In the Medical Equipment & Supplies group Wednesday morning, an analyst at Oppenheimer initiated coverage on the following stocks:

• Insulet (Nasdaq: PODD) with an Outperform rating and a $25 price target
  
• Thoratec (Nasdaq: THOR) with an Outperform rating and a $40 price target
  
• DexCom (Nasdaq: DXCM) with a Perform rating
  
• HeartWare (Nasdaq: HTWR) with a Perform rating

Check out our Ratings Insider portal to get the most comprehensive and up-to-date analyst coverage on the Street.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• KeyBanc Starts Super Micro Computer (SMCI) at Sector Weight, 'shares currently trading relatively inline with its infrastructure peer group'
• Piper Sandler Starts Kura Sushi USA Inc. (KRUS) at Neutral, 'Risk Reward as relatively balanced'
• UBS Starts Mobimo Holding AG (MOBN:SW) at Neutral